Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRD-directed DLI for Relapse Reduction in Acute Leukemia
NCT02673008Phase 3Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jan 2016
- Primary completion
- Oct 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of donor lymphocyte infusion in acute leukemia, sponsored by Nanfang Hospital, Southern Medical University. Started Jan 2016; status: completed.
02
Drugs
donor lymphocyte infusion
03
Conditions
acute leukemia
Beyond the preview
Go deeper on NCT02673008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673008.